Supply Chain | April 17, 2026
Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
The company allocated €56 million to research and development for next-generation line solutions
The company allocated €56 million to research and development for next-generation line solutions
The company reported net revenue of SEK 13.5 million for the full year 2025
The investment case for health technology in India is frequently overstated in one direction and understated in another
Revvity is positioning its technologies as a connected engine for discovery
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
Muted movement reflects consolidation phase as investors await earnings triggers
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
Subscribe To Our Newsletter & Stay Updated
